Innoviva - 21 Year Stock Price History | INVA
Historical daily share price chart and data for Innoviva since 2004 adjusted for splits and dividends. The latest closing stock price for Innoviva as of April 17, 2025 is 18.27.
- The all-time high Innoviva stock closing price was 31.90 on July 11, 2013.
- The Innoviva 52-week high stock price is 21.28, which is 16.5% above the current share price.
- The Innoviva 52-week low stock price is 14.83, which is 18.8% below the current share price.
- The average Innoviva stock price for the last 52 weeks is 17.96.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Innoviva Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2025 |
17.8978 |
17.4000 |
18.9800 |
17.1000 |
18.2700 |
5.30% |
| 2024 |
17.2377 |
16.3700 |
20.3200 |
14.4000 |
17.3500 |
8.17% |
| 2023 |
12.9066 |
13.2700 |
16.2700 |
10.7300 |
16.0400 |
21.06% |
| 2022 |
15.2545 |
17.4500 |
20.2500 |
11.6100 |
13.2500 |
-23.19% |
| 2021 |
14.1809 |
12.4800 |
18.7200 |
11.0600 |
17.2500 |
39.23% |
| 2020 |
12.5718 |
13.9300 |
15.2600 |
8.1100 |
12.3900 |
-12.50% |
| 2019 |
13.6160 |
17.3000 |
20.0600 |
10.0500 |
14.1600 |
-18.85% |
| 2018 |
15.2612 |
14.4300 |
18.2600 |
13.4400 |
17.4500 |
22.97% |
| 2017 |
12.7226 |
11.1400 |
14.7500 |
10.4300 |
14.1900 |
32.62% |
| 2016 |
11.2488 |
10.3200 |
13.7700 |
8.2300 |
10.7000 |
1.52% |
| 2015 |
13.4310 |
13.2571 |
19.5225 |
6.7800 |
10.5400 |
-22.07% |
| 2014 |
21.1900 |
27.1549 |
30.2893 |
12.1381 |
13.5248 |
-49.29% |
| 2013 |
24.5437 |
16.7867 |
31.8977 |
15.0811 |
26.6687 |
60.30% |
| 2012 |
16.7085 |
15.3354 |
23.7064 |
12.2609 |
16.6370 |
0.63% |
| 2011 |
16.9515 |
19.2029 |
21.4696 |
12.6349 |
16.5323 |
-11.85% |
| 2010 |
12.1770 |
9.9793 |
21.4248 |
7.2563 |
18.7542 |
91.82% |
| 2009 |
10.8683 |
10.5702 |
13.8243 |
8.1839 |
9.7772 |
5.49% |
| 2008 |
9.7748 |
14.5499 |
16.6147 |
4.3164 |
9.2686 |
-36.46% |
| 2007 |
22.2629 |
23.4594 |
27.5365 |
14.4601 |
14.5873 |
-36.87% |
| 2006 |
20.2582 |
16.5996 |
24.4320 |
15.2830 |
23.1079 |
37.17% |
| 2005 |
14.3864 |
13.2783 |
17.5796 |
12.3656 |
16.8466 |
25.81% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$1.132B |
$0.310B |
|
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
|
